Exact Sciences Corp. (EXAS)
NASDAQ:EXAS
Holding EXAS?
Track your performance easily

Exact Sciences (EXAS) Financial Statements

3,131 Followers

Exact Sciences Financial Overview

Exact Sciences's market cap is currently ―. The company's EPS TTM is $-0.96; its P/E ratio is -72.66; Exact Sciences is scheduled to report earnings on November 5, 2024, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 699.26M$ 637.52M$ 646.88M$ 628.34M$ 622.09M
Gross Profit$ 509.42M$ 467.42M$ 475.07M$ 459.81M$ 465.10M
EBIT$ -14.42M$ -100.48M$ -43.84M$ 8.91M$ -72.10M
EBITDA$ 38.59M$ -46.57M$ 10.33M$ 61.21M$ -23.45M
Net Income Common Stockholders$ -15.81M$ -116.44M$ -49.77M$ 843.00K$ -81.02M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 946.78M$ 652.09M$ 777.64M$ 734.41M$ 775.71M
Total Assets$ 6.67B$ 6.38B$ 6.47B$ 6.42B$ 6.36B
Total Debt$ 2.76B$ 2.56B$ 2.55B$ 2.56B$ 2.56B
Net Debt$ 1.81B$ 1.90B$ 1.78B$ 1.83B$ 1.78B
Total Liabilities$ 3.48B$ 3.24B$ 3.33B$ 3.30B$ 3.30B
Stockholders Equity$ 3.19B$ 3.13B$ 3.15B$ 3.12B$ 3.06B
Cash Flow-
Free Cash Flow$ 71.20M$ -119.96M$ 34.63M$ -5.49M$ 61.44M
Operating Cash Flow$ 107.06M$ -82.31M$ 69.55M$ 19.70M$ 96.16M
Investing Cash Flow$ -147.13M$ -171.44M$ -66.77M$ -28.28M$ 70.72M
Financing Cash Flow$ 224.60M$ -3.00M$ 10.04M$ 92.00K$ 16.04M
Currency in USD

Exact Sciences Earnings and Revenue History

Exact Sciences Debt to Assets

Exact Sciences Cash Flow

Exact Sciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis